USE OF AN IMMUNOGENIC COMPOSITION COMPRISING VZV GE, OR IMMUNOGENIC FRAGMENT THEREOF, AND A TH-1 ADJUVANT IN THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION OR AMELIORATION OF SHINGLES AND/OR POST HERPETIC NEURALGIA. COMPOSITIONS COMPRISING A TRUNCATED VZV GE ANTIGEN AND AN ADJUVANT CONTAINING QS21, CHOLESTEROL AND 3D MPL ARE ALSO CLAIMED.